Search Results 771-780 of 18256 for SARS

  1. Publications - Matthew J. Koster, M.D. - Mayo Clinic

    SARS-CoV-2 induced IgA vasculitis confirmed with SARS-CoV-2 tissue testing. JAAD Case Rep. 2024 Jan; 43:57-59. Epub 2023 Nov 25. View PubMed; Ahmed N, Skolka ...

  2. https://www.mayoclinic.org/arabic_procedure_concepts.xml

  3. Cough Causes - Mayo Clinic

    Severe acute respiratory syndrome (SARS) · Sex and COVID-19 · Sinus headaches · Sinus infection and toothache: Any connection? Sjogren syndrome · Small cell, ...

  4. Diabetes and COVID-19 - Mayo Clinic

    For more information. Barrett CE, et al. Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 years — ...

  5. Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC - Mayo Clinic

    coronavirus 2 (SARS-CoV-2), known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness. 10. Clinically ...

  6. Publications - Ellen M. Bendel-Stenzel, M.D. - Mayo Clinic

    Fetal Surgery in the Era of SARS-CoV-2 Pandemic: A Single-Institution Review. Mayo Clin Proc Innov Qual Outcomes. 2020 Dec; 4(6):717-724. Epub 2020 Aug 19 ...

  7. Study Of Tirabrutinib (ONO-4059) In Patients With Primary Central Nervous System Lymphoma (PROSPECT Study) - Mayo Clinic

    Active infection, including a HIV, cytomegalovirus infection or SARS-CoV-2, or has had, within 28 days before starting tirabrutinib treatment, an infection ...

  8. ALSENLITE: Senolytics for Alzheimer's Disease - Mayo Clinic

    Positive SARS-CoV-2 test within 30 days prior to enrollment 13. AST/ALT > 2.5x upper limit normal 14. Presence of significant liver disease with total ...

  9. Publications - Joe Zein, M.D., Ph.D. - Mayo Clinic

    Acute skeletal muscle loss in SARS-CoV-2 infection contributes to poor clinical outcomes in COVID-19 patients. J Cachexia Sarcopenia Muscle. 2022 Oct; 13 (5): ...

  10. ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 - Mayo Clinic

    Illness of any duration and has laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection as determined by polymerase ...